Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
1.030
+0.030 (3.00%)
May 13, 2025, 4:00 PM - Market closed

Artelo Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2021 2016 - 2020
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Aug '21 2016 - 2020
Market Capitalization
33482222
Upgrade
Market Cap Growth
-39.90%-23.37%-45.90%-62.41%-1.60%416.89%
Upgrade
Enterprise Value
1-1-8-111212
Upgrade
Last Close Price
1.031.061.402.897.7813.66
Upgrade
PB Ratio
1.181.200.380.430.811.85
Upgrade
P/TBV Ratio
4.134.180.460.480.872.23
Upgrade
Debt / Equity Ratio
0.150.040.000.000.000.01
Upgrade
Quick Ratio
0.271.328.0817.5723.4819.14
Upgrade
Current Ratio
0.491.448.5118.3623.9619.61
Upgrade
Return on Equity (ROE)
-190.70%-134.52%-59.63%-43.30%--93.45%
Upgrade
Return on Assets (ROA)
-89.21%-71.22%-37.09%-26.42%--54.68%
Upgrade
Return on Capital (ROIC)
-118.84%-85.74%-39.73%-27.52%--58.09%
Upgrade
Earnings Yield
-290.76%-287.20%-208.06%-122.17%-55.14%-33.33%
Upgrade
FCF Yield
-247.08%-244.06%-183.83%-97.03%-36.44%-27.52%
Upgrade
Buyback Yield / Dilution
-8.88%-8.88%-4.48%-27.04%-79.12%-403.69%
Upgrade
Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q